Referenten

Referenten des Pharma-Kongresses 2019:

• Ib Alstrup, Danish Medicines Agency
  Medicines Inspector.
• Gabriel Anderson, Novartis
  Co-lead Novartis's visual inspection expert Network.
• Dr. Abdulaziz Awad, Saudi Biotechnology Manufacturing Company
  Board Member and CEO.
• Eva-Maria Baumgartner, Syntacoll
  Validation Manager.
• Dr. Matthias Beck, Oncotec
  Manager New Business Development.
• Stefan Bieler, IDT-Biologika
  Process engineer at IDT-Biologika, Department Filling and Freeze Drying Vaccines.
• Maximilian Bischl, Roche Diagnostics
  Manager Operations.
• Dr. Clemens Borkenstein, ZETA Biopharma
  Head of Department Quality Assurance and Qualification.
• Dr. Berthold Düthorn, Robert Bosch Packaging Technology
  Vice President.
• Zinaid Dzinovic, Novartis
  Program Manager MES.
• Klaus Eichmüller, Wolnzach, c/o Regional Council Darmstadt, GMP Inspectorate, Germany
  Head of Inspectorate.
• Dr. Detlef Eisenkraetzer, Roche Diagnostics
  Director Fermentation Development.
• Sandrine Favre, Octapharma
  Head of Corporate Pharmaceutical Production.
• Klaus Feuerhelm, Regierungspräsidium Tübingen
  GMP-Inspektor.
• Dr. Andreas Grummel, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
  Apotheker, Wissenschaftlicher Direktor und Mitglied der BfArM PAT Gruppe.
• Dr. Friedrich Haefele, Boehringer Ingelheim Pharma
  Head of the department Biopharma Fill & Finish Germany.
• Dr. Martin Haerer, Rommelag CMO
  Responsible for Business Development, Technology Transfer and  Research and Development and acting as QP.
  
• Thomas Hahlgans, CSL Behring
  Leiter Instandhaltungsmanagement.
• Uwe Harenberg, GESA
• Managing Director.
• Dr. Philip Hörsch, Vetter Pharma Fertigung
  Director QA - Validation/Risk Management/Trending.
• Dr. Thilo Kaltenbach, Roland Berger (Pharma & Healthcare Competence Center)
  Senior Partner.
• Dr. Matthias Kahl, Wilco
  Head of Development and Lab Service.
  
• Kieran Keaney, Abbvie Ireland
  Senior Engineer.
• Alan Kelly, Genzyme
  Mechanical engineer in the technical development department.
• Dr. Gerald Kindermann, F. Hoffmann La-Roche
  QA and GMP Compliance Lead.
• Peter Koop, Arvato Systems
  Vice President.
• Dr. Johannes Krämer, CSL Behring
  Leiter des Engineerings.
• Felix Krumbein, Roche Diagnostics
  Head of Inspections-Systems-Support.
• Dr. Jean-Denis Mallet, ECA
  Former head of the French Inspection Department AFSSAPS.
• Dr. Thomas Meindl, Labor LS
  Division Manager.
• Didier Meyer, DMCompliance
  Consultant at DMCompliance.
• Gerd Moelgaard, ECA Validation Interest Group
  Consultant, Moelgaard Consuliting.
• Christian Mrotzek, Fresenius Kabi
  Senior Director Engineering and Technology.
• Dr. Daniel Müller, Local Authority of Baden Württemberg
  Head of GMP Inspectorate.
• Dr. Felix Oehme, Bayer
  Head of Biological Development.
• Thomas Page, FUJIFILM Diosynth Biotechnologies
  Vice President, Engineering & Asset Development.
• Thomas Reiner, Berndt+Partner
  CEO; Vorstandsmitglied der World Packaging Organisation.
• Armin Rockenschaub, GE Healthcare
  Manufacturing Engineering and Quality Engineering Leader.
• Doris Rottenbusch, Vetter Pharma-Fertigung
  Leading a team of experts in Development Service - Technology & Process Transfer.
• Knud Ryhl, Novo Nordisk
  Senior Lead Auditor / Senior Specialist.
• Prof. Farshid Sadeghipour, Lausanne University Hospital
  Head of Pharmacy.
• Yves Samson, ECA Data Integrity & IT Compliance Interest Group
  Kereon AG, CEO & e-Compliance SME.
• Dr. Ralph Sapper, Merck
  Senior Projektmanager.
• Matthias Schaar, Novartis Pharma, Stein
  Teamleader Qualification & Infrastructure in Microbiological Department.
• Gabriela Schallmeiner, Austrian QP Association
  Deputy Chair.
• Dr. Ute Schleyer, Vetter Pharma Fertigung
  Project Manager, Site & Plant Development.
• Thorsten Schlosser, Allergopharma
  Vice President Technical Operations.
• Stefan Schoettle, Roche Diagnostics
  Head of Informatics Pharma Manufacturing Mannheim.
• Dr. Andreas Schreiner, Novartis
  Leiter Validierung.
• Dr. Thomas Schwarz, Novartis
  Leiter Strategische Planung.
• Christof Specht, F. Hoffmann La-Roche
  Gesamtprojektleiter & Bauherr.
• Dr. Clemens Stief, Pfizer
  Teamleiter Produkt- und Prozess-Entwicklung.
• Dr. Frank Stieneker, Consultant und QP
  Produktentwicklung, Prozess- und Anlagendesign-Funktion.
• Christian Sturm, Sanofi
  Change Leader Site Frankfurt Biotechnology.
• Dr. Arno Terhechte, Bezirksregierung Münster
  Medicines Inspector.
• Dr. Frank Thielmann, Novartis
  Operation Excellence Leader Biologics.
• Patrick Vanhecke, GSK Vaccines
  Expert in Isolator and Aseptic Filling Technologies and Room decontamination process.
• Martin Wenzel, Roche Diagnostics
  Gruppenleiter Technik, Clinical Supply Center.